Physician profile
Lisa Batten
NPI 1538469705
$470.16
in general payments reported to CMS, 2019-2025
11 companies · $80.50 in 2025
The $80.50 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.14 · 2022: $148 · 2023: $90.69 · 2024: $123 · 2025: $80.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $105.94 | 2023-2025 | Veozah |
| Boston Scientific Corporation | $93.98 | 2023-2025 | General - Pain Management |
| Biohaven Pharmaceutical Holding Company LTD. | $69.75 | 2022 | |
| Novo Nordisk INC | $57.26 | 2022 | |
| Pfizer INC. | $29.88 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.14 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.06 | 2022 | |
| Exact Sciences Corporation | $19.72 | 2025 | The Cologuard Plus Collection Kit |
| Corcept Therapeutics | $15.75 | 2024 | Korlym |
| Vanda Pharmaceuticals INC. | $14.80 | 2024 | Fanapt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.88 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Batten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.